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Abstract
Several in vivo studies have reported the presence of immunoreactive transforming growth factor-
β's (TGF-β's) in testicular cells at defined stages of their differentiation. The most pronounced
changes in TGF-β1 and TGF-β2 immunoreactivity occurred during spermatogenesis. In the present
study we have investigated whether germ cells and Sertoli cells are able to secrete bioactive TGF-
β's in vitro, using the CCl64 mink lung epithelial cell line as bioassay for the measurement of TGF-
β. In cellular lysates, TGF-β bioactivity was only observed following heat-treatment, indicating that
within these cells TGF-β is present in a latent form. To our surprise, active TGF-β could be
detected in the culture supernatant of germ cells and Sertoli cells without prior heat-treatment.
This suggests that these cells not only produce and release TGF-β in a latent form, but that they
also release a factor which can convert latent TGF-β into its active form. Following heat-activation
of these culture supernatant's, total TGF-β bioactivity increased 6- to 9-fold. Spermatocytes are
the cell type that releases most bioactive TGF-β during a 24 h culture period, although round and
elongated spermatids and Sertoli cells also secrete significant amounts of TGF-β. The biological
activity of TGF-β could be inhibited by neutralizing antibodies against TGF-β1 (spermatocytes and
round spermatids) and TGF-β2 (round and elongating spermatids). TGF-β activity in the Sertoli cell
culture supernatant was inhibited slightly by either the TGF-β1 and TGF-β2 neutralizing antibody.
These in vitro data suggest that germ cells and Sertoli cells release latent TGF-β's. Following
secretion, the TGF-β's are converted to a biological active form that can interact with specific TGF-
β receptors. These results strengthen the hypothesis that TGF-β's may play a physiological role in
germ cell proliferation/differentiation and Sertoli cell function.
Background
The normal physiological functions of the testis are regu-
lated by the gonadotrophins luteinizing hormone (LH)
and follicle-stimulating hormone (FSH). In addition,
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locally derived paracrine factors are also postulated to
play an important role in maintaining cellular function,
growth and differentiation in the testis. A number of pep-
tide growth factors that affect the growth and metabolic
activities of testicular cell types have been identified in the
testis, including the transforming growth factor-β's (TGF-
β's) [1].
The TGF-β's are polypeptide growth factors that are multi-
functional regulators of both growth and development in
many different tissues. To date three different forms of
TGF-β have been identified in the testis. Sertoli cells and
Leydig cells in the porcine testis express TGF-β1 mRNA
[2,3]. In the adult mouse TGF-β1 and TGF-β3 mRNA's
have been shown to be expressed in the somatic cell com-
partment of the germ cell depleted testis, while TGF-β1
mRNA expression has also been detected in spermatogen-
ic cells [4]. In the rat testis TGF-β1, TGF-β2 and TGF-β3
mRNAs are expressed by Sertoli cells and peritubular/my-
oid cells. The expression pattern of these mRNAs has been
shown to undergo clear changes during testicular develop-
ment [5,6].
We have expanded these findings to the protein level and
have shown that immunoreactive TGF-β1 and TGF-β2 are
present in vivo in testicular cells at defined stages of their
differentiation [7]. TGF-β1  predominated in spermato-
cytes and early round spermatids, but as the spermatids
elongated around stages VIII-IX of the cycle of the seminif-
erous epithelium, the TGF-β1 immunoreactivity declined.
TGF-β2  was undetectable in spermatocytes and early
round spermatids, but as spermiogenesis progressed,
around stages V-VI, spermatids rapidly became positive
for TGF-β2 and remained positive as the spermatids elon-
gated. TGF-β1 immunoreactivity was present in Sertoli
cells throughout testicular development, while TGF-β2
immunoexpression rapidly declined after birth [7].
Although the observation of immunoreactive TGF-β1 and
TGF-β2 in germ cells at defined stages of their differentia-
tion suggests that these growth factors may play a physio-
logical role in germ cell differentiation, there is no
evidence that these germ cells and Sertoli cells also secrete
TGF-β's. Hence, in the present study we have investigated
whether Sertoli cells, spermatocytes, round and elongated
spermatids release TGF-β's in vitro, using the CCl64 mink
lung epithelial cell line for the measurement of TGF-β bi-
oactivity. Culture media we added to the bioassay before
and after heat-activation, in order to determine whether
these cell types secrete a factor that can activate the secret-
ed latent TGF-β1 as well.
Materials & Methods
Cell isolation
Highly purified (> 99%) Sertoli cell preparations were ob-
tained by isolating Sertoli cells from testes of 21-day-old
Wistar rats (substrain R-1 Amsterdam) as has been de-
scribed by Themmen et al. [8]. Sertoli cells were cultured
in Eagle's minimal essential medium (MEM; Gibco,
Grand Island, NY) with 0.1% BSA (fraction V; Sigma, St
Louis, MO) and antibiotics at a density of 12 × 106 cells
per 175 cm2 in 20 ml medium at 37°C in culture flasks
[8]. After a culture period of 24 h the culture supernatant
was collected and the cells were scraped from the bottom
of the culture flask, resuspended and homogenized in 2
ml phosphate buffered saline (PBS) after which both cul-
ture supernatant and cell homogenate were frozen and
stored at -20°C until further processing.
Spermatogenic cells were isolated from 40/50-day-old
Wistar rats (substrain R-1 Amsterdam) using collagenase
and trypsin treatment, and purified using sedimentation
at unit gravity (StaPut procedure) followed by density gra-
dient purification (Percoll gradients) [9]. The purity of the
cell preparations isolated according to this method, was
analysed using DNA-flow cytometry [10]: the prepara-
tions enriched in spermatocytes, round and elongated
spermatids contained more than 90% of cells with a 4C or
1C amount of DNA per cell, respectively. Spermatocytes,
round spermatids and elongated spermatids were cul-
tured in PBS with 0.1% BSA supplemented with 2 mM so-
dium pyruvate, 6 mM DL-lactate and antibiotics
according to the method described by Jutte et al (11). The
cell densities were 17 × 106 cells and 80 × 106 cells, respec-
tively for spermatocytes and round spermatids, in 35 ml
PBS at 32°C in culture flasks (Gibco). Elongated sperma-
tids were cultured at a density of 16 × 106 cells, in 18 ml
PBS at 32°C in culture flasks (Gibco). Under these culture
conditions the viability and capacity of protein synthesis
and RNA synthesis and processing remains remarkably
constant, as has been shown previously by our group (11–
13). After a culture period of 24 h the spermatogenic cells
were spun down, resuspended and homogenized in 2 ml
PBS after which both supernatant and cell homogenates
were frozen and stored at -20°C until further processing.
All experimental procedures involving the use of rats,
were approved by the ethical committee for laboratory an-
imal welfare of the Faculty of Medicine, Erasmus Univer-
sity, Rotterdam.
Bioassay for TGF-β
TGF-β activity in cell homogenates and cell culture super-
natants was determined using a CCl64 mink lung epithe-
lial cell biological assay [14]. The cells were collected
during their logarithmic growth phase and suspended at a
concentration of 8 × 104  cells/ml in DMEM (Gibco)Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/3
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containing 0.2% fetal calf serum (Gibco). Fifty µl of the
suspension was added to flat bottom 96-well plates and
incubated at 37°C for 5 h. Samples, either assayed directly
or heat activated (5 min, 80°C), were then added to the
wells at various dilutions with or without the addition of
neutralizing rabbit anti-TGF-β1 or anti-TGF-β2 antibodies
(gift from dr. AJM Van den Eijnden-Van Raaij, Hubrecht
Laboratory, Utrecht, The Netherlands), as has been de-
scribed before [15]. After 20 h the cells were pulsed with 1
µCi [3H]thymidine (Amersham, Amsterdam; specific ac-
tivity 0.7–1.1 × 108MBq/mmol) for 4 h and the incorpo-
rated radioactivity was counted. The inhibition of the
proliferation of the cells was related to a standard curve of
recombinant human TGF-β1 (Genzyme, Cambridge, MA).
All experiments were carried out in triplicate. Values are
expressed as mean ± SD. For statistical analysis the two-
tailed Student's t-test was used.
Results
In cell lysates of spermatocytes, round and elongating
spermatids, and Sertoli cells cultured for 24 h, TGF-β bio-
activity was only measurable after heat activation. Elon-
gating spermatids contained the highest levels of TGF-β
bioactivity (Table 1).
TGF-β bioactivity was also measured in the supernatants
of these cultures. Even without heat treatment considera-
ble amounts of active TGF-β were detectable in the medi-
um of all cell types. Following heat activation the amount
of TGF-β increased 6- to 9-fold; the highest active TGF-β
content was measured in the supernatant of the spermato-
cyte cultures (Table 1). TGF-β bioactivity in the culture su-
pernatant's was higher than in the cell lysates, suggesting
that most TGF-β did not accumulate within the cells but
was released during culture.
In order to confirm that it was indeed TGF-β that inhibit-
ed the growth of the CCl64 mink lung cells, and to inves-
tigate the types of TGF-β that were secreted by the
testicular cells, neutralizing TGF-β1 and TGF-β2 antibodies
were mixed with the culture supernatants 30 min before
addition to the mink lung epithelial cell bioassay. As
shown in Figure 1 TGF-β1 antiserum clearly reduced the
growth inhibitory effects of the spermatocyte, round sper-
matid and Sertoli cell supernatants in CCL64 mink lung
cells, while the effect of this antibody in the supernatant
of elongated spermatids was less pronounced. The TGF-β2
antiserum reduced the growth inhibitory effects of round
spermatid supernatant, while the effects in spermatocyte,
round spermatid and Sertoli cell supernatant's was mini-
mal (Fig. 1).
Discussion
TGF-β has been purified from several nonneoplastic tis-
sues, transformed cells and from conditioned media of
several cell lines [16]. In the testis, Sertoli cells, peritubu-
lar/myoid cells and germ cells have been shown to con-
tain mRNAs for different types of TGF-β's [2,4–6].
Secretion of TGF-β1 by Sertoli cell-germ cell co-cultures
has been demonstrated by Western blotting [17]. The data
of the present study showed that cell lysates of highly pu-
rified germ cells and Sertoli cells contained TGF-β, which
became activated following heat-treatment. In addition,
these cells released TGF-β in vitro during a 24 h culture pe-
riod. The highest level of intracellular TGF-β bioactivity
was found in elongating spermatids, while spermatocytes
were the testicular cell type that released most TGF-β dur-
ing the culture period, although round and elongated
spermatids and Sertoli cells also secreted significant
amounts of this growth factor.
The activity of TGF-β in the culture supernatants could be
inhibited considerably by neutralizing antibodies raised
Table 1: TGF-β activity in lysates of isolated testicular cells (Tissue) and in cell culture. 
TGF-β activity in pg × 10-6 cells/24 h
Tissue Supernatant
Testicular cell type Not activated Heat activated Not activated Heat activated
Spermatocytes ND 5.0 ± 0.6 693.0 ± 231.0 6405.0 ± 105.0
Round spermatids ND 1.5 ± 0.2 361.4 ± 100.6 2537.5 ± 262.5
Elongating spermatids ND 103.1 ± 9.4 596.3 ± 138.4 2981.3 ± 393.8
Sertoli cells ND 16.7 ± 6.7 233.3 ± 66.7 1458.3 ± 208.3
Supernatant, using the CCl64 mink lung epithelial cell line as a bioassay for the measurement of TGF-β activity. Spermatocytes, round spermatids, 
elongated spermatids and Sertoli cells were cultured for 24 h. TGF-β activity in the different preparations was measured before and after heat-acti-
vation of the samples (for details see Materials & Methods). The incubations were carried out in triplicate (values are presented as means ± SD); the 
data being representative of at least three different experiments. ND: not detectable.Reproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/3
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against TGF-β1  (spermatocytes, round spermatids) and
TGF-β2  (elongating spermatids). The TGF-β1  antibody
had a less pronounced inhibitory effect on the bioactivity
in elongated spermatid conditioned medium, while the
same was the case for the TGF-β2 antibody in conditioned
medium of spermatocytes and round spermatids. Howev-
er, one has to keep in mind that the ED50's for growth in-
hibition of CCl64 mink lung epithelial cells by the
different isoforms of TGF-β are not the same. Therefore, it
is not possible to extrapolate the growth inhibitory effects
to amounts of TGF-β1 and TGF-β2 released by spermato-
cytes, and round and elongating spermatids. The data of
the present study fit very well with our immunohisto-
chemical observations, where we found intense
immunostaining for TGF-β1 in spermatocytes and round
spermatids. TGF-β2 immuno-reactivity was low or absent
in these cell types. In contrast, TGF-β2 immunoreactivity
was high in elongating spermatids, while in these cells
TGF-β1 immunostaining was negligible [7].
TGF-β activity in the Sertoli cell culture supernatant was
slightly inhibited following the addition of the TGF-β1 or
TGF-β2 neutralizing antibody. These results further extend
previous observations by Avallet et al [17] who could not
detect TGF-β1 secretion by Sertoli cells in vitro by Western
blotting. Based on studies by Mullaney & Skinner [6] who
showed that in Sertoli cells from 21-day-old rats TGF-β3
mRNA is the type of TGF-β that is predominantly ex-
pressed and secreted, we presume that remaining bioactiv-
ity in the Sertoli cell supernatant is probably due to the
presence of TGF-β3.
Whereas many cell types have the potential to produce
TGF-β in vitro, they have been reported to secrete TGF-β in
an inactive (latent) form which is unable to bind to its re-
ceptors [18,19]. The CCl64 mink lung epithelial cell line
which we used as a bioassay for the detection of TGF-β ac-
tivity, does not detect latent TGF-β. Latent TGF-β can,
however, be activated by physiochemical treatment
Figure 1
Effect of anti-TGF-β1 (filled bars) and anti-TGF-β2 (hatched bars) antibodies on growth inhibition of mink lung CCl64 cells by 
heat treated culture supernatants of spermatocytes (sp.cytes), round spermatids (r. spert.), elongated spermatids (e.spert.) and 
Sertoli cells (S.c.). The dilutions of the culture supernatants that gave maximal growth inhibition were equivalent to 100% TGF-
β activity (open bars). The final concentration of both antibodies used in this assay was 10 µg/ml. The values, which are 
expressed as percentage of residual TGF-β activity, represent means ± SD
0
20
40
60
80
100
120
Sp.cytes R.spert. E.spert.   S.c.
%
 
r
e
s
i
d
u
a
l
 
T
G
F
-
b
e
t
a
 
a
c
t
i
v
i
t
yReproductive Biology and Endocrinology 2003, 1 http://www.RBEj.com/content/1/1/3
Page 5 of 6
(page number not for citation purposes)
[18,20]. In the present study TGF-β was measured in
culture supernatants before and after activiation by heat
treatment. Surprisingly, not only latent, but active TGF-β
was also present in the culture supernatants of the diverse
cell types. In contrast, in cell homogenate's bioactive TGF-
β could only be measured after heat-activation. These re-
sults indicate that primary cell cultures of germ cells and
Sertoli cells release TGF-β in a latent form and that this la-
tent protein is converted into a bioactive form in the cul-
ture medium, presumably by the concomitant release of a
factor that can convert this growth factor into its active
form. The nature of this "converting" factor is unknown.
Since the cell cultures used in the experiments described
were highly purified, it is not likely that contaminating
cells are responsible for the secretion of this factor. Only a
few other studies have reported the presence of an activat-
ed (bioactive) form of TGF-β in culture supernatant's of
primary cells, transformed and non-transformed cell lines
was observed [18,21–23].
In an immunohistochemical study we have shown that
there exists a marked transition from TGF-β1 to TGF-β2
during the cycle of the seminiferous epithelium [7]. The
present investigation expands these findings with the ob-
servation that germ cells and Sertoli cells release these dif-
ferent types of TGF-β's in vitro as well. The physiological
relevance of TGF-βs as growth- and differentiation-regula-
tory factors appears to rest on the regulation of its activa-
tion [15]. Once activated, these TGF-β's have extremely
short half-lives and are transported only within a short
range [24], suggesting that these transforming growth fac-
tors presumably exert their action in a paracrine fashion
within the seminiferous tubules.
So far actions of TGF-β on testicular cells have only been
demonstrated in vitro. Morera et al. [25] and Benahmed
and colleagues [26] have for instance shown that TGF-β
can inhibit the stimulatory actions of FSH on Sertoli cell
aromatase activity by attenuating cAMP levels in vitro.
Other groups have reported that TGF-β increases inhibin
" mRNA levels [27], lactate production [28] and prote-
oglycan synthesis [29]. TGF-β3 has been implicated to per-
turb the inter-Sertoli tight junction permiability barrier
possibly by affecting occludin, zonula occludens-1 and
claudin-11, genes expressed in junctional complexes (30).
These observationd indicated that Sertoli cells presumably
possess binding sites for TGF-β. Reports of direct effects of
TGF-β on germ cells are limited. Hakovinta and colleagues
[31] have demonstrated that TGF-β1 increased DNA syn-
thesis in preleptotene spermatocytes in seminiferous tu-
bules, suggesting the presence of functional receptors on
these cells. Indeed, in more recent studies it has been
shown that Sertoli cells, spermatocytes and spermatids ex-
press TGF-β receptor types I and/or II [27,32]. Taken to-
gether, these observations further strengthen the
hypothesis that TGF-β's are important paracrine/autocrine
factors within the seminiferous tubules and suggest the ex-
istence of stage dependent interaction and communica-
tion between neighboring Sertoli and germ cells.
In summary, the present study demonstrates the presence
of several types of latent TGF-β's within spermatogenic
cells and Sertoli cells which are released by these cells as
well. Following release they are converted to a biological
active form that can interact with specific TGF-β receptors.
The presence of active TGF-β within the seminiferous tu-
bules may have important implications for the role of
TGF-β's in the function of Sertoli cells, and germ cell
development.
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